Cytek earnings
WebFeb 28, 2024 · Cytek Biosciences, Inc. provided revenue guidance for the full year 2024. For the year, the company expects revenue in the range of $225 million to $235 million, representing growth of 37% to 43% over full year 2024. This includes approximately $20 million of revenue contribution from the acquisition of Luminex's Flow Cytometry and … WebFeb 28, 2024 · Cytek Biosciences, Inc. is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high …
Cytek earnings
Did you know?
WebApr 8, 2024 · Cytek Biosciences Inc.’s market cap currently stands at around $1.18 billion, with investors looking forward to this quarter’s earnings report slated for Feb 28, 2024. Analysts project the company’s earnings per share (EPS) to be $0.03, which has seen fiscal year 2024 EPS growth forecast to increase to $0.21 and about $0.33 for fiscal ... WebNov 9, 2024 · 2024 Outlook: Cytek Biosciences continues to expect full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million vs. consensus of …
WebCytek Biosciences Reports Second Quarter 2024 Financial Results Earnings Per Share Estimated Reported Quarterly Earnings Surprise Amount Yearly Earnings Forecast Quarterly Earnings... WebFeb 28, 2024 · Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results Full year 2024 revenue increased 28%, or 34% on constant currency basis, compared to prior year Provides full year 2024 revenue guidance of $225 million to $235 million, or growth of 37% to 43% over full year 2024
WebApr 11, 2024 · The Zacks Consensus Estimate for Encompass Health’s 2024 earnings is pegged at $3.07 per share, indicating a 7.7% increase from the prior-year reported figure. The consensus mark for 2024... WebSep 30, 2024 · Cytek Biosciences continues to expect full year 2024 revenue to be closer to the high end of the range of $160 million to $168 million. Webcast Information. Cytek will host a conference call to discuss the third quarter 2024 financial results on Wednesday, November 9, 2024, at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
WebCytek Biosciences, Inc. (CTKB) Q2 Earnings Surpass Estimates Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 50% and 2.85%, respectively, for the quarter ended June 2024.
WebFeb 28, 2024 · Cytek Biosciences, Inc. (CTKB) delivered earnings and revenue surprises of 40% and 3.07%, respectively, for the quarter ended December 2024. Do the numbers … flower facts for childrenWebFeb 23, 2024 · Cytek Biosciences expects full year 2024 revenue to be in the range of $160 million to $168 million. Cytek will host a conference call to discuss the fourth quarter … flower fairs什么意思中文WebApr 11, 2024 · Cytek Biosciences Inc’s price-earnings (P/E) ratio is currently at 568.0, which is high compared to the Advanced Medical Equipment & Technology industry median of 32.6. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. greek words to know when travelingWebApr 12, 2024 · Cytek Biosciences, Inc. (CTKB) Q3 2024 Earnings Call Transcript SA Transcripts Sat, Nov. 12, 2024 Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2024 Results Earnings Call Transcript... flowerfair telfordWebApr 13, 2024 · Cytek Biosciences, Inc. (NASDAQ:CTKB – Get Rating) CEO Wenbin Jiang sold 20,000 shares of Cytek Biosciences stock in a transaction that occurred on Monday, April 10th.The stock was sold at an average price of $8.88, for a total transaction of $177,600.00. Following the sale, the chief executive officer now owns 7,684,439 shares … flower fairs是什么意思WebNov 8, 2024 · Cytek Biosciences, Inc. ( NASDAQ: CTKB) Q3 2024 Earnings Conference Call November 8, 2024 4:30 PM ET Company Participants Wenbin Jiang - Chief Executive Officer Patrik Jeanmonod - Chief... greek words with interesting meaningsWebNov 9, 2024 · Cytek Biosciences, Inc. , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $40.48 million for the quarter ended September 2024, missing the Zacks... greek words with cool meanings